BSE | NSE

GlaxoSmithKline Pharmaceuticals Ltd.

500660 GLAXO Group (A)

26 Jul,15:29

2710.80
34.05 (1.27%)

HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist

Refresh

Zoom

Day

6Mn

Volume	Prev close	Day's H/L (Rs.)	52wk H/L (Rs.)	Mkt Cap (Rs. Cr)	GlaxoSmithKline Pharmaceuticals Ltd. BUY SELL
2,089	2,676.75	2,739.25 - 2,690.00	2,759.00 - 1,376.50	45,920.96	GlaxoSmithKline Pharmaceuticals Ltd. BUY SELL

(Rs. Crore)

Financial Results of GlaxoSmithKline Pharmaceuticals Ltd.

	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20
Sales	3,407.25	3,216.34	3,217.51	3,193.73	3,224.68
Operating profit	900.65	799.41	755.83	694.95	658.45
Interest	1.80	1.81	1.99	3.53	6.34
Gross profit	1,022.33	899.12	830.06	801.61	729.67
EPS (Rs)	34.51	35.87	99.79	21.11	6.50

See more in Research Center »

Statements:Balance Sheet | P&L | Cash Flow

More:Dividend | Bonus | Share Holding | Capital Structures | Ratios

About GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia

News for Pharmaceuticals and health care

Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue

Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...

Jul 26, 2024 22:32

Sebi Confirms Order Against 12 in V Marc India Fraud

Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.

Jul 26, 2024 22:25

PM GatiShakti Evaluates 5 Infra Projects: Road, Rail

Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.

Jul 26, 2024 22:10

Fortune Wealth Targets Rs 500 cr Multi-Cap Fund

Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.

Jul 26, 2024 22:05

Kargil Vijay Diwas: India Post Releases Commemorative Stamp

India Post commemorates the 25th anniversary of Kargil Vijay Diwas with a special postage stamp, honoring the bravery of Indian armed forces.

Jul 26, 2024 22:04

More News »

Top News

G20 Agrees to Tax Super-Rich, Brazil Leads Effort

Finance ministers from G20 nations agree to work toward taxing the super-rich, a significant step toward addressing global inequality. Brazil's proposal for a 2% minimum tax on billionaires is...

Jul 27, 2024 03:35

Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue

Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...

Jul 26, 2024 22:32

Sebi Confirms Order Against 12 in V Marc India Fraud

Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.

Jul 26, 2024 22:25

PM GatiShakti Evaluates 5 Infra Projects: Road, Rail

Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.

Jul 26, 2024 22:10

Fortune Wealth Targets Rs 500 cr Multi-Cap Fund

Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.

Jul 26, 2024 22:05

More Top News »

Report Card

PE Ratios

78.54

EPS (Rs.)

34.51

Sales (Rs. Cr)

910.87

Face Value (Rs.)

Net Profit Margin (%)

17.16

Last Bonus

1:1

Last Dividend(%)

320

Return on Average Equity

32.6

BSE Announcements from GlaxoSmithKline Pharmaceuticals Ltd. (See all)

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate - 4 day(s) ago

Disclosure Under Clause 30 - 5 day(s) ago

Compare 'GlaxoSmithKline Pharmaceuticals Ltd.' with other stocks

Sun Pharmaceutical Industries Ltd.
1,665.20
Compare

Cipla Ltd.
1,499.90
Compare

Divi's Laboratories Ltd.
4,549.75
Compare

Zydus Lifesciences Ltd.
1,205.60
Compare

Dr. Reddy's Laboratories Ltd.
6,854.20
Compare

Torrent Pharmaceuticals Ltd.
3,087.85
Compare

Apollo Hospitals Enterprise Ltd.
6,388.60
Compare

Max Healthcare Institute Ltd.
926.50
Compare

Lupin Ltd.
1,801.15
Compare

Alkem Laboratories Ltd.
5,178.80
Compare

Mutual Funds Invested

Goldman Sachs CNX 500 Fund - Direct Plan - Growth

0.12%

Goldman Sachs CNX 500 Fund - Growth

0.12%

Goldman Sachs CNX 500 Fund - Direct Plan - Dividend

0.12%

Goldman Sachs CNX 500 Fund - Dividend

0.12%

Most Active

Change (Rs.)

Cipla Ltd.
78.35
(5.22%)

Wockhardt Ltd.
-8.95
(-1.04%)

Gland Pharma Ltd.
16.20
(0.81%)

Glenmark Pharmaceuti
14.05
(0.99%)

Biocon Ltd.
6.90
(1.91%)

Lupin Ltd.
38.40
(2.13%)

Pfizer Ltd.
-77.45
(-1.46%)

Aurobindo Pharma Ltd
24.05
(1.77%)

AstraZeneca Pharma I
222.85
(3.21%)

Divi's Laborato
242.40
(5.33%)

Share Price » Fundamentals » Financial » Technicals » Trade Now »

Peers

LTP
Change (Rs.)
Change %
Mkt Cap (Rs. Cr)
Volume

Cipla Ltd.
1,578.25
78.35
5.22 %
127,459.48
122,838

Wockhardt Ltd.
850.00
-8.95
-1.04 %
13,039.00
7,546

Gland Pharma Ltd.
2,020.15
16.20
0.81 %
33,292.08
3,999

Glenmark Pharmaceuti
1,437.85
14.05
0.99 %
40,576.13
45,340

Biocon Ltd.
368.60
6.90
1.91 %
44,254.12
298,258

Lupin Ltd.
1,839.55
38.40
2.13 %
83,883.48
170,018

Aurobindo Pharma Ltd
1,386.45
24.05
1.77 %
81,232.11
14,006

Pfizer Ltd.
5,223.35
-77.45
-1.46 %
23,870.71
2,095

AstraZeneca Pharma I
7,160.00
222.85
3.21 %
17,900.00
4,822

Divi's Laborato
4,792.15
242.40
5.33 %
127,231.59
49,427

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us

Add GlaxoSmithKline Pharmaceuticals Ltd. to your Portfolio
Date of purchase
Quantity
Purchase price
Exchange	BSE BSE NSE NSE

GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd.

Financial Results of GlaxoSmithKline Pharmaceuticals Ltd.

About GlaxoSmithKline Pharmaceuticals Ltd.

News for Pharmaceuticals and health care

Top News

Report Card

BSE Announcements from GlaxoSmithKline Pharmaceuticals Ltd. (See all)

Compare 'GlaxoSmithKline Pharmaceuticals Ltd.' with other stocks

Mutual Funds Invested

Most Active

REDIFFGURUS

I am 28 with monthly salary 70000 I have MF of...

My husband is 50 and I am 47. We have a combined...

I have hdfc small cap, multicap, flexicap funds all...

I am interested in investing 1 Lakh per month in...

Hello Sir,I am 32 yrs old, Engineer, Married,...

Sir I have invested in Jeevan Shanti 2 CR for 9...

Sir, I had initially started SIP in mutual funds via...

GlaxoSmithKline Pharmaceuticals Ltd. performance snapshot

Peers

Stocks

Mutual Funds

Investment tracking

Add GlaxoSmithKline Pharmaceuticals Ltd. to your Portfolio

Add GlaxoSmithKline Pharmaceuticals Ltd. to your Watchlist

Add GlaxoSmithKline Pharmaceuticals Ltd. to your Watchlist Alert me if price...
Goes above Rs.
Goes below Rs.